Literature DB >> 18718172

All-trans retinoic acid inhibits the increases in fibronectin and PAI-1 induced by TGF-beta1 and Ang II in rat mesangial cells.

Xia Liu1, Lei Lü, Bei-bei Tao, Yi-chun Zhu.   

Abstract

AIM: To investigate the effect of all-trans RA (atRA) on the increases in plasminogen activator inhibitor-1 (PAI-1) and fibronectin that are induced by transforming growth factor-beta1 (TGF-beta1) and angiotensin II (Ang II) in cultured rat glomerular mesangial cells.
METHODS: Subconfluent glomerular mesangial cells were serum-starved for 48 h and pretreated with atRA with subsequent stimulation of TGF-beta1 and Ang II. Protein expressions of cell-associated fibronectin and PAI-1 in glomerular mesangial cells were evaluated by Western blot analysis. mRNA expression of RA receptors in glomerular mesangial cells was examined by RT-PCR.
RESULTS: Retinoic acid receptor-alpha, -gamma (RAR-alpha, -gamma) and retinoid X receptor-alpha, -beta, -gamma (RXR-alpha, -beta, -gamma) mRNA were expressed in rat glomerular mesangial cells. atRA pretreatment effectively reduced fibronectin expression in glomerular mesangial cells stimulated with TGF-beta 1 or Ang II for 48 h. TGF-beta 1 stimulated PAI-1 expression reached a maximum at 5 h. atRA didn't affect the early (5 h) PAI-1 induction by TGF-beta 1, but markedly attenuated the sustained (48 h) PAI-1 induction. atRA also decreased the prolonged effect of Ang II on PAI-1 expression.
CONCLUSION: These results indicate that atRA inhibits the increases in fibronectin that are induced by TGF-beta1 and Ang II in cultured glomerular mesangial cells. The data also suggest that this effect of atRA is associated with a change in PAI-1 levels.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18718172     DOI: 10.1111/j.1745-7254.2008.00849.x

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  10 in total

1.  An in vitro model for the pro-fibrotic effects of retinoids: mechanisms of action.

Authors:  A C Rankin; B M Hendry; J P Corcoran; Q Xu
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

2.  Amelioration of glomerulosclerosis with all-trans retinoic acid is linked to decreased plasminogen activator inhibitor-1 and α-smooth muscle actin.

Authors:  Xia Liu; Lei Lü; Bei-bei Tao; Ai-ling Zhou; Yi-chun Zhu
Journal:  Acta Pharmacol Sin       Date:  2011-01       Impact factor: 6.150

3.  All-trans retinoic acid and sodium butyrate enhance natriuretic peptide receptor a gene transcription: role of histone modification.

Authors:  Prerna Kumar; Ramu Periyasamy; Subhankar Das; Smitha Neerukonda; Indra Mani; Kailash N Pandey
Journal:  Mol Pharmacol       Date:  2014-04-08       Impact factor: 4.436

4.  A molecular profile of focal segmental glomerulosclerosis from formalin-fixed, paraffin-embedded tissue.

Authors:  Jeffrey B Hodgin; Alain C Borczuk; Samih H Nasr; Glen S Markowitz; Viji Nair; Sebastian Martini; Felix Eichinger; Courtenay Vining; Celine C Berthier; Matthias Kretzler; Vivette D D'Agati
Journal:  Am J Pathol       Date:  2010-09-16       Impact factor: 4.307

5.  Inhibition of HDAC enhances STAT acetylation, blocks NF-κB, and suppresses the renal inflammation and fibrosis in Npr1 haplotype male mice.

Authors:  Prerna Kumar; Venkateswara R Gogulamudi; Ramu Periasamy; Giri Raghavaraju; Umadevi Subramanian; Kailash N Pandey
Journal:  Am J Physiol Renal Physiol       Date:  2017-05-31

6.  Retinoic acid and sodium butyrate suppress the cardiac expression of hypertrophic markers and proinflammatory mediators in Npr1 gene-disrupted haplotype mice.

Authors:  Umadevi Subramanian; Prerna Kumar; Indra Mani; David Chen; Isaac Kessler; Ramu Periyasamy; Giri Raghavaraju; Kailash N Pandey
Journal:  Physiol Genomics       Date:  2016-05-06       Impact factor: 3.107

7.  Altered retinoic acid metabolism in diabetic mouse kidney identified by O isotopic labeling and 2D mass spectrometry.

Authors:  Jonathan M Starkey; Yingxin Zhao; Rovshan G Sadygov; Sigmund J Haidacher; Wanda S Lejeune; Nilay Dey; Bruce A Luxon; Maureen A Kane; Joseph L Napoli; Larry Denner; Ronald G Tilton
Journal:  PLoS One       Date:  2010-06-14       Impact factor: 3.240

8.  PPARs in the Renal Regulation of Systemic Blood Pressure.

Authors:  Tamás Roszer; Mercedes Ricote
Journal:  PPAR Res       Date:  2010-06-08       Impact factor: 4.964

Review 9.  Retinoid and TGF-β families: crosstalk in development, neoplasia, immunity, and tissue repair.

Authors:  Qihe Xu; Jeffrey B Kopp
Journal:  Semin Nephrol       Date:  2012-05       Impact factor: 5.299

10.  A New Prospect for the Treatment of Nephrotic Syndrome Based on Network Pharmacology Analysis.

Authors:  Rini Varghese; Anuradha Majumdar
Journal:  Curr Res Physiol       Date:  2022-01-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.